Trial Profile
A study to investigate the early response to certolizumab pegol in patients with rheumatoid arthritis by ultrasound assessment
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 29 Aug 2016
Price :
$35
*
At a glance
- Drugs Certolizumab pegol (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- 10 Feb 2016 New trial record